<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Tuberculosis: Natural history, microbiology, and pathogenesis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Tuberculosis: Natural history, microbiology, and pathogenesis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Tuberculosis: Natural history, microbiology, and pathogenesis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            C Fordham von Reyn, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John Bernardo, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 15, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Mycobacterium tuberculosis
         </em>
         causes tuberculosis (TB) and is a leading infectious cause of death in adults worldwide [
         <a href="#rid1">
          1
         </a>
         ]. The human host serves as a natural reservoir for
         <em>
          M. tuberculosis
         </em>
         . (See
         <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">
          "Epidemiology of tuberculosis"
         </a>
         .)
        </p>
        <p>
         The microbiology and pathogenesis of TB will be reviewed here. The immunology of this infection is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8026.html" rel="external">
          "Immunology of tuberculosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13826069">
         <span class="h1">
          NATURAL HISTORY OF INFECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Inhalation of aerosol droplets containing
         <em>
          M. tuberculosis
         </em>
         with subsequent deposition in the lungs leads to one of four possible outcomes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immediate clearance of the organism
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary disease: immediate onset of active disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Latent infection
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reactivation disease: onset of active disease many years following a period of latent infection
        </p>
        <p>
        </p>
        <p>
         Among individuals with latent infection and no underlying medical problems, reactivation disease occurs in approximately 5 to 10 percent of cases [
         <a href="#rid2">
          2-4
         </a>
         ]. The risk of reactivation is markedly increased in patients with HIV and other medical conditions [
         <a href="#rid5">
          5,6
         </a>
         ]. These outcomes are determined by the interplay of factors attributable to both the organism and the host.
        </p>
        <p class="headingAnchor" id="H13826076">
         <span class="h2">
          Primary disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Much of our understanding of the natural course of TB comes from human autopsy data prior to the era of antituberculosis drugs and from experimental animal models [
         <a href="#rid7">
          7-11
         </a>
         ]. Among the approximately 5 to 10 percent of infected individuals who develop active disease, approximately half will do so within the first two to three years following infection.
        </p>
        <p>
         The tubercle bacilli establish infection in the lungs after they are carried in droplets small enough to reach the alveolar space (5 to 10 microns). If the innate defense system of the host fails to eliminate the infection, the bacilli proliferate inside alveolar macrophages, which may migrate away from the lungs to enter other tissue.
        </p>
        <p>
         While in the lungs, macrophages produce cytokines and chemokines that attract other phagocytic cells, including monocytes, other alveolar macrophages, and neutrophils, which eventually form a nodular granulomatous structure called a tubercle. If the bacterial replication is not controlled, the tubercle enlarges and the bacilli enter local draining lymph nodes. This leads to lymphadenopathy, a characteristic manifestation of primary TB. The lesion (called Ghon focus) produced by the expansion of the tubercle into the lung parenchyma and lymph node enlargement or calcification together comprise the Ranke complex [
         <a href="#rid12">
          12
         </a>
         ]. Bacteremia also may accompany initial infection.
        </p>
        <p>
         The bacilli continue to proliferate until an effective cell-mediated immune (CMI) response develops, usually 2 to 10 weeks following initial infection; this occurs in more than 90 percent of exposed infected individuals. A successful CMI contains viable organisms at sites to which they have migrated before sensitization was achieved. In the lung, failure of the host to mount an effective CMI response and tissue repair leads to progressive destruction of lung. Tumor necrosis factor (TNF)-alpha, reactive oxygen and nitrogen intermediates, and the contents of cytotoxic cells (granzymes, perforin), which function to eliminate
         <em>
          M. tuberculosis
         </em>
         , may also contribute to collateral host cell damage and the development of caseating necrosis. Hence, much of TB pathology results from an infected host's proinflammatory immune response to the tubercle bacilli. Caseous necrosis is frequently associated with TB but can also be caused by other organisms, including syphilis, histoplasmosis, cryptococcosis, and coccidioidomycosis. (See related topics.)
        </p>
        <p>
         Unchecked bacterial growth may lead to hematogenous spread of bacilli to produce disseminated TB. Disseminated disease with lesions resembling millet seeds has been termed miliary TB. Bacilli can also spread mechanically by erosion of the caseating lesions into the airways; at this point, the host becomes infectious to others. In the absence of treatment, death ensues in up to 80 percent of cases [
         <a href="#rid13">
          13
         </a>
         ]. The remaining patients develop chronic disease or recover. Chronic disease is characterized by repeated episodes of healing by fibrotic changes around the lesions and tissue breakdown. Complete spontaneous eradication of the bacilli is rare.
        </p>
        <p class="headingAnchor" id="H13826083">
         <span class="h2">
          Reactivation disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reactivation TB results from proliferation of a previously latent bacteria seeded at the time of the primary infection. Among individuals with latent infection and no underlying medical problems, it has generally been estimated that the lifetime risk of reactivation disease after an index infection is 5 to 10 percent, with a 5 percent risk in the two to five years following infection and another 5 percent risk over the remaining lifetime [
         <a href="#rid4">
          4
         </a>
         ]. A study from Australia of close contacts of TB cases reported a risk of 11 percent in the five years following infection; the risk rose to 14.5 percent after adjusting for death and loss to follow-up [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Immunosuppression is clearly associated with reactivation TB, although it is not clear what specific host factors maintain the infection in a latent state and what triggers the latent infection to break containment and become active. Immunosuppressive conditions associated with reactivation TB include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         HIV infection and AIDS
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chronic and end-stage kidney disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diabetes mellitus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Malignant lymphoma
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Corticosteroid use
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inhibitors of TNF-alpha and its receptor
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diminution in cell-mediated immunity associated with age
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cigarette smoking [
         <a href="#rid6">
          6,15,16
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         The disease process in reactivation TB tends to be localized (in contrast with primary disease); in general, there is little regional lymph node involvement and less caseation. The lesion typically occurs at the lung apices, and disseminated disease is unusual unless the host is severely immunosuppressed.
        </p>
        <p>
         Prior TB infection, contained as latent TB, confers some protection against subsequent TB disease [
         <a href="#rid17">
          17
         </a>
         ]. One review evaluating 23 paired cohorts (total more than 19,000 individuals) noted that individuals with latent TB had 79 percent lower risk of progressive TB following reinfection compared with uninfected individuals [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         On the other hand, prior TB disease is associated with an increased risk of subsequent TB disease. Studies in both HIV-uninfected and HIV-infected individuals with one episode of active TB have noted a two- to fourfold increased risk of a second episode of active TB compared with individuals without prior active disease [
         <a href="#rid18">
          18,19
         </a>
         ]. A study from South Africa including 612 patients treated for TB documented recurrent disease in 18 percent of cases over a five-year follow-up period; recurrence occurred after successful treatment in 14 percent of cases [
         <a href="#rid20">
          20
         </a>
         ]. By comparing DNA fingerprints of the
         <em>
          M. tuberculosis
         </em>
         isolates from the first and second episodes of TB, the investigators showed that 77 percent of the recurrences were new infections rather than relapse [
         <a href="#rid20">
          20
         </a>
         ]. The rate of reinfection TB was four times the rate of new TB. The increased risk of active disease in those with prior TB may be a reflection of the high prevalence of the disease and therefore high transmission frequency in a community with a large number of high-risk hosts.
        </p>
        <p>
         The term "remote infection" refers to infection that progresses to active TB after ≥2 years of a new infection [
         <a href="#rid21">
          21
         </a>
         ]. Worldwide, particularly in high-burden countries, most clinical TB reflects recently transmitted infection (&lt;2 years prior to development of active disease) [
         <a href="#rid21">
          21
         </a>
         ]. Therefore, it has been proposed that treatment of latent TB infection be prioritized for those who are recently infected.
        </p>
        <p>
         In low-burden countries, a higher proportion of TB cases occurs due to remote infection among foreign-born residents [
         <a href="#rid22">
          22-24
         </a>
         ]. As an example, in the United States in 2016, a majority of foreign-born persons who developed TB had resided in the United States for more than five years before diagnosis [
         <a href="#rid25">
          25
         </a>
         ]. The percentage varied by place of birth; more than two-thirds of those born in Mexico or the Philippines and about 50 percent of those from India and other countries had resided in the United States for more than five years before diagnosis [
         <a href="#rid25">
          25
         </a>
         ]. It is possible that these individuals became reinfected when they visited their country of origin and developed disease after returning to the United States [
         <a href="#rid21">
          21
         </a>
         ]; however, the likelihood of such reinfections progressing to active disease is low [
         <a href="#rid26">
          26,27
         </a>
         ].
        </p>
        <p>
         In a systematic review of 312 mathematic modeling studies to assess the incidence of progression from latent infection to active disease, the median annual incidence was found to decrease from 77 to 1.7 cases per 1000 between the 1 and 20 years after infection among individuals with no risk factors [
         <a href="#rid28">
          28
         </a>
         ]. Median cumulative incidence increased from 7.7 to 14.2 percent between 1 and 20 years after infection [
         <a href="#rid28">
          28
         </a>
         ]. However, these modeling estimates varied greatly across studies with 20-year cumulative incidence and were often at odds with empiric observations. Many of these progression studies are limited by the inability to precisely determine the time of exposure that leads to a latent infection.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. tuberculosis
         </em>
         belongs to the genus
         <em>
          Mycobacterium
         </em>
         , which includes more than 50 other species, often collectively referred to as nontuberculous mycobacteria. TB is defined as a disease caused by members of the
         <em>
          M. tuberculosis
         </em>
         complex, which include the tubercle bacillus (
         <em>
          M. tuberculosis
         </em>
         ),
         <em>
          M. bovis
         </em>
         ,
         <em>
          M. africanum
         </em>
         ,
         <em>
          M. microti
         </em>
         ,
         <em>
          M. canetti
         </em>
         ,
         <em>
          M. caprae
         </em>
         ,
         <em>
          M. pinnipedii,
         </em>
         and
         <em>
          M. orygis
         </em>
         [
         <a href="#rid29">
          29,30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5343.html" rel="external">
          "Microbiology of nontuberculous mycobacteria"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Cell envelope
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cell envelope is a distinguishing feature of the organisms belonging to the genus
         <em>
          Mycobacterium
         </em>
         . The mycobacterial cell envelope is composed of a core of three macromolecules covalently linked to each other (peptidoglycan, arabinogalactan, and mycolic acids) and a lipopolysaccharide, lipoarabinomannan (LAM), which is thought to be anchored to the plasma membrane [
         <a href="#rid31">
          31
         </a>
         ]. The outermost layer, the mycobacterial outer membrane (MOM), consists of a lipid bilayer structure [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Mycolic acid, a beta-hydroxy fatty acid, is the major constituent of the cell envelope, accounting for more than 50 percent by weight; this structure defines the genus. Glycolipids are attached to the outside of the envelope layer through a connection to the mycolic acid layer; proteins are also embedded in this cell wall complex. Glycolipid components are implicated in "cord formation," whereby TB bacilli clump together forming a serpiginous structure seen on microscopy [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Staining characteristics
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cell wall components give
         <em>
          Mycobacterium
         </em>
         its characteristic staining properties. The organism stains positive with Gram stain. The mycolic acid structure confers the ability to resist destaining by acid alcohol after being stained by certain aniline dyes, leading to the term acid-fast bacillus (AFB).
        </p>
        <p>
         Microscopy to detect AFB (using Ziehl-Neelsen or Kinyoun stain) is the most commonly used procedure to diagnose TB in the world, especially in countries with limited laboratory capacity. A specimen must contain at least 10
         <sup>
          4
         </sup>
         colony forming units (CFU)/mL to yield a positive smear [
         <a href="#rid34">
          34
         </a>
         ]. Microscopy of specimens stained with a fluorochrome dye (such as auramine O) provides an easier, more efficient, and approximately a 10-fold more sensitive alternative. However, microscopic detection of mycobacteria does not distinguish
         <em>
          M. tuberculosis
         </em>
         from nontuberculous mycobacteria.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Growth characteristics
         </span>
         <span class="headingEndMark">
          —
         </span>
         A distinguishing feature of
         <em>
          M. tuberculosis
         </em>
         is its slow growth rate. In artificial media and animal tissues, its generation time is about 20 to 24 hours (as opposed to 20 minutes for organisms such as
         <em>
          Escherichia coli
         </em>
         ).
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Isolation in the laboratory
         </span>
         <span class="headingEndMark">
          —
         </span>
         Artificial media used to cultivate
         <em>
          M. tuberculosis
         </em>
         include potato- and egg-based media, such as Middlebrook 7H10 or 7H11, or albumin in an agar base, such as the Löwenstein-Jensen medium [
         <a href="#rid35">
          35
         </a>
         ]. A liquid medium, such as Middlebrook 7H9, is used for subcultures and for propagating the bacillus to extract DNA for molecular diagnostic and strain-typing procedures [
         <a href="#rid36">
          36
         </a>
         ]. Three to four weeks are required to recover the organism, depending on the initial quantity of organisms in the specimen.
        </p>
        <p>
         Broth-based culture systems to improve the speed and sensitivity of detection exist. The BACTEC 460 system is based upon Middlebrook 7H12 medium containing 14C palmitic acid with a mixture of antibiotics (PANTA) to suppress other bacterial growth [
         <a href="#rid37">
          37
         </a>
         ]. The addition of NAP (p-nitro-alpha-acetylamino-beta-hydroxypropiophenone) in the medium suppresses growth of other
         <em>
          M. tuberculosis
         </em>
         complex organisms, such as
         <em>
          M. bovis
         </em>
         , but does not differentiate
         <em>
          M. tuberculosis
         </em>
         from other nontuberculous mycobacteria. BACTEC 460 has been phased out by its manufacturer.
        </p>
        <p>
         Bacterial growth is indicated by the detection of 14C released by
         <em>
          M. tuberculosis
         </em>
         as it metabolizes the palmitic acid. In AFB smear-positive specimens, the BACTEC system can detect
         <em>
          M. tuberculosis
         </em>
         in approximately 8 days (compared with approximately 14 days for smear-negative specimens) [
         <a href="#rid38">
          38,39
         </a>
         ]. However, the high cost of the equipment and the need for radioactive material that requires disposal exclude its use in most endemic settings.
        </p>
        <p>
         Other broth-based systems include Septi-Chek AFB (BBL) and the Mycobacterial Growth Indicator Tube (MGIT) [
         <a href="#rid40">
          40,41
         </a>
         ]. Septi-Chek AFB is a biphasic system comprised of a capped bottle containing modified Middlebrook 7H9 broth under CO
         <sub>
          2
         </sub>
         and a paddle coated with solid agar, such as Middlebrook 7H11 and Löwenstein-Jensen media [
         <a href="#rid40">
          40
         </a>
         ]. The recovery rate of
         <em>
          M. tuberculosis
         </em>
         complex from AFB smear-negative specimens by this procedure is about 15 to 30 percent higher than conventional media, and the average number of days to recovery is two to five days shorter [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         The MGIT 960 system used in the United States is based on Middlebrook 7H9 broth containing silicon rubber impregnated with ruthenium pentahydrate that serves as a fluorescence-quenching oxygen sensor. As oxygen is consumed by metabolizing bacteria, fluorescence of the liquid growth medium is detected visually. Among smear-negative samples in a study of 1500 clinical specimens, the recovery rate of the
         <em>
          M. tuberculosis
         </em>
         complex was about 15 percent less by the MGIT system (68 percent) compared with that obtained by the radiometric BACTEC system, but the mean time to detection was similar (9.9 versus 9.7 days) [
         <a href="#rid41">
          41,42
         </a>
         ]. The lack of need for expensive instrumentation and radioactive materials renders MGIT widely acceptable and suitable in many laboratories.
        </p>
        <p>
         A similar broth-based and colorimetric detection system is the MB/BacT system. In this system, a colorimetric sensor is embedded at the bottom of a bottle, and, when carbon dioxide is produced by a growing microorganism, the sensor changes from dark green to yellow. This change in color is monitored continuously by a detection device. A systematic review of this system (compared with the BACTEC 460) found that the MB/BacT system had a sensitivity of 96 to 100 percent and a specificity of 78 to 100 percent [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Identification of the organism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once the organism is isolated, identification is based on morphologic and biochemical characteristics, although nucleic acid–based detection methods have obviated many of the conventional tests.
         <em>
          M. tuberculosis
         </em>
         is identified by its rough, nonpigmented, so-called "corded" colonies on albumin-based agars. It is typically positive in the niacin test, has a weak catalase activity, which is inactivated at 68ºC, and reduces nitrate [
         <a href="#rid35">
          35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p>
         The only other major slow-growing
         <em>
          Mycobacterium
         </em>
         that is niacin test–positive is
         <em>
          M. simiae
         </em>
         . Although all members of the mycobacteria species produce niacin (usually undetectable by the niacin test), the differences in the activity of the enzymes involved in the salvage pathway of nicotinamide adenine dinucleotide (NAD) biosynthesis in
         <em>
          M. tuberculosis
         </em>
         determines niacin positivity in
         <em>
          M. tuberculosis
         </em>
         . Niacin accumulates in
         <em>
          M. tuberculosis
         </em>
         because nicotinamidase, which converts nicotinamide to niacin, is several-fold more active, and the enzyme that recycles niacin to produce NAD is less active than in members of most other mycobacterial species [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         The niacin, nitrate reductase, and catalase tests are the three biochemical tests most frequently used to distinguish
         <em>
          M. tuberculosis
         </em>
         from other mycobacterial species [
         <a href="#rid35">
          35
         </a>
         ]. Tests for pyrazinamidase production as well as susceptibility to thiophen-2-carboxylic acid hydrazide (TCH) will distinguish
         <em>
          M. tuberculosis
         </em>
         from
         <em>
          M. bovis
         </em>
         , another member of the
         <em>
          M. tuberculosis
         </em>
         complex.
         <em>
          M. bovis
         </em>
         does not express pyrazinamidase (or nicotinamidase) and is susceptible to less than 5 mcg/mL of TCH [
         <a href="#rid35">
          35,45
         </a>
         ]. Clinical isolates of
         <em>
          M. tuberculosis
         </em>
         lacking pyrazinamidase activity have been described that contain nucleotide point mutations in the gene (
         <em>
          pncA
         </em>
         ) that encodes pyrazinamidase; these isolates are resistant to
         <a class="drug drug_general" data-topicid="9836" href="/z/d/drug information/9836.html" rel="external">
          pyrazinamide
         </a>
         (PZA), one of the first-line drugs used to treat TB [
         <a href="#rid46">
          46
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8027.html" rel="external">
          "Epidemiology and molecular mechanisms of drug-resistant tuberculosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Genome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The complete genome sequence of
         <em>
          M. tuberculosis
         </em>
         strain H37Rv was reported in 1998 [
         <a href="#rid47">
          47,48
         </a>
         ]. The following characteristics have been described in this laboratory strain:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The genome has 4,411,529 base pairs, containing about 4000 genes, with a G+C content of 65.6 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consistent with the recognized structure of its cell envelope, many genes are devoted to lipid biosynthesis and metabolism.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The organism contains lipid and polyketide biosynthetic enzymes that are normally found in mammals and plants and about 250 enzymes involved in fatty acid degradation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It has only 11 complete pairs of two-component regulatory systems, as opposed to more than 30 such pairs in organisms like
         <em>
          E. coli
         </em>
         .
        </p>
        <p>
        </p>
        <p>
         Approximately 10 percent of the genes in
         <em>
          M. tuberculosis
         </em>
         are devoted to the production of two families of glycine-rich proteins called PE (proline-glutamine motifs) and PPE (proline-proline-glutamine motifs). These genes are composed of polymorphic GC-rich repetitive sequences (PGRSs) and major polymorphic tandem repeats, which have served as a basis for strain-typing
         <em>
          M. tuberculosis
         </em>
         clinical isolates [
         <a href="#rid49">
          49,50
         </a>
         ]. The functions of these families of proteins are unknown. However, the PE/PGRS genes in
         <em>
          M. marinum
         </em>
         , the cause of fish and amphibian TB, are preferentially expressed inside granulomas and macrophages [
         <a href="#rid51">
          51
         </a>
         ]. Others have suggested that some PE proteins serve as outer membrane nutrient transport proteins [
         <a href="#rid52">
          52
         </a>
         ], including heme acquisition [
         <a href="#rid53">
          53
         </a>
         ]. These proteins have characteristics of Type VII secretion apparatus-associated substrates and that various subgroups of PE and PPE are likely to exhibit different biological functions [
         <a href="#rid54">
          54,55
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of approaches to study
         <em>
          M. tuberculosis
         </em>
         virulence have been devised, including those examining
         <em>
          M. tuberculosis
         </em>
         virulence factors, bacterial factors associated with intracellular survival or survival in an animal model, and genotypic differences in the community prevalence of clinical strains.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Virulence factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following
         <em>
          M. tuberculosis
         </em>
         products were described as virulence factors prior to the introduction of molecular biology tools to study
         <em>
          M. tuberculosis
         </em>
         [
         <a href="#rid56">
          56-61
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mycolic acid glycolipids and trehalose dimycolate ("cord factor"), which can elicit granuloma formation in animal tissue
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Catalase-peroxidase, which resists the host cell oxidative response
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sulfatides and trehalose dimycolate, which can trigger toxicity in animal models
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lipoarabinomannan (LAM), which can induce cytokines and resist host oxidative stress
        </p>
        <p>
        </p>
        <p>
         These products and their variants are found in many members of the
         <em>
          Mycobacterium
         </em>
         species, so their specific role in
         <em>
          M. tuberculosis
         </em>
         pathogenesis is not clear.
        </p>
        <p>
         Many additional so-called virulence factors have been identified by molecular biology techniques.
         <em>
          M. tuberculosis
         </em>
         "virulence factors" are often defined as bacterial products whose disruption (based on comparison with wild-type
         <em>
          M. tuberculosis
         </em>
         ) leads to diminished ability of the mutant to attach to or enter mammalian cells in vitro, decreased growth in vitro in artificial medium or inside mammalian cells, attenuation in an animal infection model, decreased ability to induce cytokines associated with disease in macrophages infected ex vivo, inability to evade host immune effector molecules, and inability to induce changes (eg, inhibition of metabolism) in cellular targets outside of itself [
         <a href="#rid62">
          62,63
         </a>
         ]. With
         <em>
          M. tuberculosis,
         </em>
         these factors may include cell wall lipids, proteins, and their regulatory factors; secreted proteins and their regulators; lipid transporters; metabolic pathways; and other proteins of unknown function [
         <a href="#rid64">
          64
         </a>
         ]. Virulence factors may also be identified epidemiologically by comparing
         <em>
          M. tuberculosis
         </em>
         strains implicated in community outbreaks to other less frequently represented clinical or laboratory strains [
         <a href="#rid65">
          65-71
         </a>
         ].
        </p>
        <p>
         One common approach to study virulence phenotype of an intracellular pathogen is to identify bacterial surface products that mediate uptake of the organism into non-phagocytic cells. The first bacterial product to be identified in this way is the invasin protein of
         <em>
          Yersinia pseudotuberculosis
         </em>
         [
         <a href="#rid72">
          72
         </a>
         ]. In the early 1990s, a similar approach was used to identify a protein (known as mycobacterial cell entry protein, or Mce1A) that conferred upon a nonpathogenic
         <em>
          E. coli
         </em>
         an ability to invade HeLa cells [
         <a href="#rid73">
          73
         </a>
         ]. The significance of
         <em>
          M. tuberculosis
         </em>
         entering epithelial cells in TB pathogenesis is not clear; most studies examining
         <em>
          M. tuberculosis
         </em>
         –mammalian cell interactions focus on professional phagocytic cells (macrophages and dendritic cells). It should be noted, however, that the initial site of lung infection by
         <em>
          M. tuberculosis
         </em>
         is the alveolar air space, which is composed of type I and type II pneumocytes; these are epithelial cells. Type I cells comprise about 96 percent of the alveolar surface area; type II cells cover about 4 percent of the surface area but comprise 60 percent of all the alveolar epithelial cells [
         <a href="#rid74">
          74
         </a>
         ]. Thus,
         <em>
          M. tuberculosis
         </em>
         is most likely to encounter and enter pneumocytes before they are taken up by alveolar macrophages. Little is known about the in vivo interaction of
         <em>
          M. tuberculosis
         </em>
         with alveolar epithelial cells.
        </p>
        <p>
         Mce1A is encoded by a gene located in a 13-gene operon containing genes encoding integral cell wall proteins [
         <a href="#rid47">
          47
         </a>
         ]. Disruption of this operon leads to enhanced virulence of this mutant compared with wild type in mouse models [
         <a href="#rid75">
          75,76
         </a>
         ]. This observation may relate to
         <em>
          M. tuberculosis
         </em>
         ' ability to establish latent infection in vivo (see below).
        </p>
        <p>
         There are three other homologues of
         <em>
          mce1
         </em>
         operon (
         <em>
          mce2
         </em>
         ,
         <em>
          mce3
         </em>
         ,
         <em>
          mce4
         </em>
         ) elsewhere in the chromosome arranged in the same manner as the
         <em>
          mce1
         </em>
         operon. Phylogenomic analyses of the
         <em>
          mce
         </em>
         operons suggest that they may encode adenosine triphosphate (ATP) binding cassette (ABC) transporters, which may be involved in lipid importation, and
         <em>
          mce4
         </em>
         may play a role in cholesterol import [
         <a href="#rid77">
          77,78
         </a>
         ]. A functional disruption of a fatty acyl-coenzyme A (CoA) synthetase gene
         <em>
          fadD5
         </em>
         in the
         <em>
          mce1
         </em>
         operon caused the mutant to become attenuated in mice and to exhibit diminished growth in minimum medium supplied with mycolic acid as the only carbon source [
         <a href="#rid79">
          79
         </a>
         ]. This led to a hypothesis that live
         <em>
          M. tuberculosis
         </em>
         may recycle mycolic acids from dying
         <em>
          M. tuberculosis
         </em>
         inside granulomas for their long-term persistence in a host [
         <a href="#rid79">
          79
         </a>
         ]. The
         <em>
          mce1
         </em>
         operon has been proposed to encode a transporter system for importing mycolic acids located in the outer leaflet of
         <em>
          M. tuberculosis
         </em>
         cell wall [
         <a href="#rid64">
          64,78,80,81
         </a>
         ]. Disruption of a 14-gene
         <em>
          mce1
         </em>
         operon was shown to lead to changes in more than 400 lipid species in a laboratory strain of
         <em>
          M. tuberculosis
         </em>
         compared with its wild-type counterpart [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         The functional role of
         <em>
          mce2
         </em>
         and
         <em>
          mce3
         </em>
         operons is not yet known, but Pandey and Sassetti have shown that
         <em>
          mce4
         </em>
         may serve as a transporter of host cell cholesterol and that it was needed by
         <em>
          M. tuberculosis
         </em>
         to survive in mice during chronic phase of infection [
         <a href="#rid64">
          64
         </a>
         ]. Another protein, LucA, has been proposed to interact with
         <em>
          mce1
         </em>
         - and
         <em>
          mce4-
         </em>
         encoded subunit proteins to facilitate import of fatty acids and cholesterol, respectively [
         <a href="#rid83">
          83
         </a>
         ]. As noted below, lipids are a crucial carbon source of energy in vitro and in vivo and hence for
         <em>
          M. tuberculosis
         </em>
         ' long-term survival inside a host. (See
         <a class="medical medical_review" href="/z/d/html/8026.html" rel="external">
          "Immunology of tuberculosis"
         </a>
         .)
        </p>
        <p>
         Differences in structure, composition, and metabolism of the cell wall lipid molecules contribute to differences in clinical outcome in mammalian hosts [
         <a href="#rid84">
          84
         </a>
         ]. In vivo, during chronic phase of infection,
         <em>
          M. tuberculosis
         </em>
         metabolizes lipids rather than carbohydrates [
         <a href="#rid61">
          61,85
         </a>
         ]. This shift occurs via a bypass system (glyoxylate shunt) in the Krebs cycle when carbon substrates for glycolysis become limited. The enzymes involved are isocitrate lyases 1 and 2 (
         <em>
          ICL1
         </em>
         /
         <em>
          2
         </em>
         ), which allow the utilization of fatty acids as a sole carbon source [
         <a href="#rid86">
          86,87
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8026.html" rel="external">
          "Immunology of tuberculosis"
         </a>
         .)
        </p>
        <p>
         The
         <em>
          M. tuberculosis
         </em>
         cell wall contains three classes of mycolic acids: alpha, keto, and methoxy mycolates. The relative composition of oxygenated mycolates influences growth of
         <em>
          M. tuberculosis
         </em>
         inside macrophages and in vivo [
         <a href="#rid88">
          88
         </a>
         ]. An
         <em>
          M. tuberculosis
         </em>
         mutant lacking trans cyclopropane rings (
         <em>
          cmaA2
         </em>
         mutant) in its methoxy and keto-mycolic acids becomes hypervirulent in the mouse model of infection [
         <a href="#rid89">
          89
         </a>
         ]. On the other hand, another cyclopropane synthase gene mutant (
         <em>
          pcaA
         </em>
         ) lacking
         <em>
          cis
         </em>
         cyclopropane rings in its alpha-mycolates is attenuated [
         <a href="#rid90">
          90
         </a>
         ]. Other lipid molecules shown to have an effect on innate and adaptive immune response includes lipoglycans, sulfolipids, and phthiocerol dimycocerosate [
         <a href="#rid61">
          61,91-93
         </a>
         ].
        </p>
        <p>
         Use of signature-tagged transposon mutagenesis to create
         <em>
          M. tuberculosis
         </em>
         mutants has identified several other candidate genes associated with virulence in the mouse model; these have included genes encoding protein secretion systems [
         <a href="#rid94">
          94
         </a>
         ] as well as products involved in lipid biosynthesis [
         <a href="#rid95">
          95
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         secretion systems include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The ESX-1 system, also known as type VII secretion system involved in the secretion of immunodominant proteins ESAT-6 and CFP-10, has been shown to promote escape of
         <em>
          M. tuberculosis
         </em>
         or its products into the cytoplasm [
         <a href="#rid94">
          94,96,97
         </a>
         ]. One such product phthiocerol dimycocerosates has been shown to act in concert with the ESX-1 secretion system to facilitate macrophage phagosomal rupture [
         <a href="#rid98">
          98
         </a>
         ]. This secretion system is located in an
         <em>
          M. tuberculosis
         </em>
         chromosome locus called the region of difference (RD-1). RD-1 gene mutants of
         <em>
          M. tuberculosis
         </em>
         demonstrate macrophage growth attenuation in mice [
         <a href="#rid99">
          99,100
         </a>
         ]. In addition, the RD-1 locus is absent in all Bacille Calmette-Guérin (BCG) vaccine strains, which is believed to be the basis for the attenuation of BCG. ESX-1 homologues have been identified in other pathogenic and nonpathogenic bacteria, and its role in pathogenesis is not fully understood.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sec secretion system (also called the general secretion pathway) is an essential secretion pathway found in all bacterial species.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The twin arginine transporter (TAT) translocates across the plasma membrane protein substrates with double arginine residues at the N-terminus. Its role in pathogenesis in mycobacteria is not certain, but the same system found in other pathogens, such as
         <em>
          Pseudomonas aeruginosa
         </em>
         , enterohemorrhagic
         <em>
          E. coli
         </em>
         , and
         <em>
          Legionella pneumophila
         </em>
         , is required for virulence [
         <a href="#rid101">
          101-103
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Factors associated with intracellular and in vivo fate of M. tuberculosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In mice,
         <em>
          M. tuberculosis
         </em>
         can be observed inside alveolar macrophages and dendritic cells in the lungs about 14 days after aerosol infection [
         <a href="#rid104">
          104
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         enters these cells after binding to a variety of receptors on these cells, including C-type lectin receptors (mannose receptor, DC-SIGN), scavenger receptors, and complement receptors [
         <a href="#rid105">
          105
         </a>
         ]. It is believed that the engagement of certain receptors can determine the intracellular fate of
         <em>
          M. tuberculosis
         </em>
         .
        </p>
        <p>
         In addition,
         <em>
          M. tuberculosis
         </em>
         lipids, including lipoarabinomannan, lipomannans, phosphatidylinositol mannosides, and a 19-kdal lipoprotein, are considered pathogen-associated molecular pattern (PAMP) molecules recognized by toll-like receptor (TLR)-2 [
         <a href="#rid106">
          106,107
         </a>
         ]. Engagement of these ligands by TLR-2 on macrophages induces a proinflammatory response, including the expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-1b, and IL-12 [
         <a href="#rid91">
          91,108
         </a>
         ]. TLR-4 may also engage
         <em>
          M. tuberculosis
         </em>
         PAMPs [
         <a href="#rid109">
          109,110
         </a>
         ]. Different clinical strains of
         <em>
          M. tuberculosis
         </em>
         have been shown to induce distinct patterns of proinflammatory response after engaging these receptors on macrophages, which determine the clinical outcome of an infection [
         <a href="#rid111">
          111
         </a>
         ]. Recognition of
         <em>
          M. tuberculosis
         </em>
         by cytosolic sensor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) has been implicated in the induction of type I interferon (IFN) response, but the importance of this response in TB pathogenesis or
         <em>
          M. tuberculosis
         </em>
         in vivo survival in mice or humans is not established [
         <a href="#rid112">
          112-119
         </a>
         ].
        </p>
        <p>
         The cyclic di-nucleotides (CDNs) represent another group of PAMPs that serve as targets of the host cytoplasmic surveillance pathway [
         <a href="#rid120">
          120,121
         </a>
         ]. Bacterial CDNs (cyclic di-AMP and cyclic-di-GMP) bind to stimulator of interferon genes (STING) and induce type I interferons (IFN-alpha/beta) which elicit autophagy, an innate immunity mechanism important for controlling intracellular infection [
         <a href="#rid122">
          122,123
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         produces cyclic-di-AMP from ATP or ADP [
         <a href="#rid124">
          124
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         that over-expresses cyclic di-AMP can activate the interferon regulatory factor pathway to generate increased amounts of IFN-beta, which leads to macrophage autophagy [
         <a href="#rid125">
          125
         </a>
         ].
        </p>
        <p>
         Once inside the phagosomal compartment,
         <em>
          M. tuberculosis
         </em>
         may inhibit the maturation of the phagosome. Phagosomal maturation requires conversion of Rab5 into GTP-bound Rab7 and the generation of phosphatidylinositol 3-phosphate (PI3P) in the phagosomal membrane [
         <a href="#rid126">
          126,127
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         products can inhibit these processes [
         <a href="#rid128">
          128,129
         </a>
         ]. Thus, from the very early phase of infection,
         <em>
          M. tuberculosis
         </em>
         can initiate control of its intracellular fate.
        </p>
        <p>
         Autophagy is a cellular process by which cytoplasmic organelles are targeted for lysosomal degradation inside macrophages. Similarly, autophagy can target intracellular pathogens for clearance [
         <a href="#rid123">
          123,130
         </a>
         ]. Autophagy has been suggested to play a role in
         <em>
          M. tuberculosis
         </em>
         control [
         <a href="#rid131">
          131
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         co-localizes with autophagy-associated proteins such as ATG5, ATG12, ATG16L1, NDP52, BECN1, and LC3 in phagosomal compartments inside cultured cells [
         <a href="#rid132">
          132-135
         </a>
         ]. However, the importance of autophagy in
         <em>
          M. tuberculosis
         </em>
         control remains uncertain.
        </p>
        <p>
         Once
         <em>
          M. tuberculosis
         </em>
         establishes an infection, an important pathogenic feature is the ability of the organism to establish latent infection, which can then give rise to reactivation disease. Since reactivation TB is the most common form of the disease, bacterial factors associated with latency and transition from latency to active disease are important virulence factors.
        </p>
        <p>
         <em>
          M. tuberculosis
         </em>
         has a particular predilection for the lungs. In immunocompetent mice, virulent strains of
         <em>
          M. tuberculosis
         </em>
         grow progressively in the lungs but not in the spleen or liver [
         <a href="#rid136">
          136
         </a>
         ]. Even in severe combined immunodeficient (SCID) mice,
         <em>
          M. bovis
         </em>
         BCG (a relatively avirulent [vaccine] strain) grows faster in the lungs than in other organs [
         <a href="#rid137">
          137
         </a>
         ]. In the mouse model, fewer organisms are required to establish a lung lesion by the inhalation than by intravenous challenge [
         <a href="#rid136">
          136
         </a>
         ]. None of the other pathogenic
         <em>
          Mycobacterium
         </em>
         species appears to share this tissue tropism. The factors associated with
         <em>
          M. tuberculosis
         </em>
         that facilitate this unique characteristic are unknown.
        </p>
        <p>
         A nonhuman primate model using cynomolgus macaques has provided novel insights into the host-pathogen relationship in TB infection and disease in humans [
         <a href="#rid138">
          138,139
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H630675818">
         <span class="h2">
          Metabolic factors associated with bacterial survival
         </span>
         <span class="headingEndMark">
          —
         </span>
         An in vitro model has been developed that mimics the physiologic state of
         <em>
          M. tuberculosis
         </em>
         during latency in vivo [
         <a href="#rid140">
          140
         </a>
         ]. When
         <em>
          M. tuberculosis
         </em>
         is grown under microaerophilic conditions, a state called nonreplicating, persistent (NRP1) is produced and glycine dehydrogenase activity is induced. In contrast, growth under anaerobic conditions produces a state called NRP2 in which glycine dehydrogenase activity decreases, but the organism still survives as long as the loss of oxygen occurred slowly and it passed through the NRP1 stage for a period of time. When oxygen is reintroduced to organisms grown anaerobically, the pathogen goes out of the NRP2 state. Such an in vitro system could potentially be used to examine differential gene expression and thus to identify bacterial factors specifically required under these growth conditions.
        </p>
        <p>
         Bacterial survival in stationary phase growth is sometimes used as an in vitro model for studying intracellular persistence. A sigma factor gene
         <em>
          sigF
         </em>
         has been identified in
         <em>
          M. tuberculosis
         </em>
         [
         <a href="#rid141">
          141
         </a>
         ]. This gene is a homologue of alternate sigma factor gene (
         <em>
          rpoS
         </em>
         ), which is important for stationary phase survival of
         <em>
          E. coli
         </em>
         and
         <em>
          Salmonella
         </em>
         spp. In
         <em>
          M. tuberculosis
         </em>
         ,
         <em>
          sigF
         </em>
         is expressed during stationary phase, nitrogen depletion, and cold shock but not during exponential phase growth.
        </p>
        <p>
         One study identified at least seven proteins specifically expressed during the stationary phase growth of
         <em>
          M. tuberculosis
         </em>
         ; the predominant expressed protein was an alpha-crystallin-like heat shock protein (
         <em>
          acr
         </em>
         ) [
         <a href="#rid142">
          142
         </a>
         ].
         <em>
          Acr
         </em>
         transcript was also induced in
         <em>
          M. tuberculosis
         </em>
         inside macrophages;
         <em>
          acr
         </em>
         gene replacement by homologous recombination in
         <em>
          M. tuberculosis
         </em>
         H37Rv led to impaired growth of the organism inside mouse bone marrow–derived macrophages [
         <a href="#rid143">
          143
         </a>
         ]. Thus,
         <em>
          acr
         </em>
         appears to be important for intracellular survival and replication. Since alpha-crystallin heat shock protein is found in a variety of cell types, its specific role in the observed phenotype of
         <em>
          M. tuberculosis
         </em>
         needs further elucidation.
        </p>
        <p>
         Several investigators have reported that isocitrate lyase (
         <em>
          icl
         </em>
         ), an enzyme essential for fatty acid metabolism, is specifically upregulated during growth of
         <em>
          M. tuberculosis
         </em>
         inside macrophages [
         <a href="#rid86">
          86,144,145
         </a>
         ]. There are two
         <em>
          icl
         </em>
         genes in
         <em>
          M. tuberculosis
         </em>
         ; the predicted proteins are 27 percent identical. In a mouse model of
         <em>
          M. tuberculosis
         </em>
         infection, deletion of both
         <em>
          icl
         </em>
         genes led to complete impairment of intracellular replication and rapid elimination of the double mutant from the lungs [
         <a href="#rid146">
          146
         </a>
         ].
        </p>
        <p>
         The above studies suggest that bacterial latency is associated with a hypoxic state in the host. Using a whole genome microarray, a large number of genes that are induced under defined hypoxic conditions were identified [
         <a href="#rid147">
          147
         </a>
         ]. One of these genes was found to be a transcriptional regulator involved in the induction of
         <em>
          acr
         </em>
         ,
         <em>
          dosR
         </em>
         [
         <a href="#rid148">
          148
         </a>
         ]. Whether
         <em>
          dosR
         </em>
         is essential for
         <em>
          M. tuberculosis
         </em>
         to establish latent infection or is merely a "housekeeping" stress response regulator for the bacillus to respond to a hypoxic condition has yet to be determined. The
         <em>
          dosR
         </em>
         genes are also present in nontuberculous mycobacteria (NTM) and may contribute to the cross-protection against TB afforded by prior NTM infection [
         <a href="#rid149">
          149
         </a>
         ].
        </p>
        <p>
         It is not clear whether any of the observations made with in vitro models or non-human animal models of latency are predictive of human latent infection. Thus far, no
         <em>
          M. tuberculosis
         </em>
         factors associated with progression from a paucibacillary state of latent infection to multibacillary state of disease have been identified. Identification of such factors could lead to targeted intervention (drugs, vaccines) to prevent such transition, which would make a major contribution to TB control.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Differences in virulence of clinical isolates
         </span>
         <span class="headingEndMark">
          —
         </span>
         Genotyping of
         <em>
          M. tuberculosis
         </em>
         isolates has demonstrated a number of clades that account for a large proportion of new TB cases in different geographic regions, suggesting that such strains may be more virulent than others.
         <em>
          M. tuberculous
         </em>
         lineages have been associated with clinical manifestations of disease. In one study, for example, East Asian lineage was less likely to be associated with extrapulmonary TB than Euro-American, Indo-Oceanic, or East-African Indian lineage [
         <a href="#rid150">
          150
         </a>
         ]. Improved understanding of the role of MTB lineages may provide insights into pathogenicity, infectiousness, progression from infection to active disease, and, perhaps, response to treatment.
        </p>
        <p>
         The W-Beijing family of
         <em>
          M. tuberculosis
         </em>
         strains has a global distribution and appears to have a selective advantage facilitating rapid expansion in regions with high background TB incidence [
         <a href="#rid151">
          151-153
         </a>
         ]. The biological reasons for this observation are not fully understood. These strains have been documented to cause outbreaks involving multidrug-resistant organisms, although in some regions the majority of W-Beijing strains remain drug susceptible [
         <a href="#rid154">
          154-156
         </a>
         ].
         <em>
          M. tuberculosis
         </em>
         Beijing genotype strains appear capable of withstanding TB treatment, even in the absence of drug resistance [
         <a href="#rid157">
          157
         </a>
         ]. W-Beijing strains have been associated with extrathoracic disease and HIV infection, although it is not clear whether HIV infection has contributed to the emergence of these strains [
         <a href="#rid155">
          155,158,159
         </a>
         ]. In experimental animal models, these strains were highly virulent and BCG vaccination was not protective [
         <a href="#rid65">
          65,160,161
         </a>
         ].
        </p>
        <p>
         Another strain called CB3.3 caused over 10 percent of new TB cases in New York City between 1992 and 1994 [
         <a href="#rid66">
          66
         </a>
         ]. This strain, susceptible to all anti-TB drugs, was found to be resistant to reactive nitrogen intermediates (RNI) generated in vitro by acidified
         <a class="drug drug_general" data-topicid="85782" href="/z/d/drug information/85782.html" rel="external">
          sodium nitrite
         </a>
         [
         <a href="#rid66">
          66
         </a>
         ]. A strain called CDC1551, also found to be resistant to RNI and reactive oxygen intermediates (ROI), caused a large outbreak in a rural area near the Kentucky–Tennessee border in 1994 to 1996 [
         <a href="#rid67">
          67,162
         </a>
         ].
        </p>
        <p>
         Another strain called PG004, responsible for a large cluster of TB cases in one northern California community, was not resistant to these effector molecules. Instead, in mice, this strain produced relatively mild lung disease, in which loosely organized granulomas apparently failed to limit the spread of infection and allowed the escape of
         <em>
          M. tuberculosis
         </em>
         into alveolar air spaces [
         <a href="#rid68">
          68
         </a>
         ]. This study suggested that an
         <em>
          M. tuberculosis
         </em>
         strain that causes mild lung disease may allow individuals with subclinical disease to be under recognized in the community and therefore more time to spread infection in the population. Therefore, such strains would be overly represented in a community. This demonstrates that the predominance of an
         <em>
          M. tuberculosis
         </em>
         strain in a community is not necessarily a marker of enhanced pathogenicity (eg, transmissibility is not equivalent to virulence).
        </p>
        <p>
         A large school outbreak in the United Kingdom was caused by an
         <em>
          M. tuberculosis
         </em>
         strain called CH in 2001. Among 254 newly infected children, 77 developed active disease within a year of exposure [
         <a href="#rid163">
          163
         </a>
         ]. Formerly called Lineage 15, strain RFL15 (based on
         <em>
          IS6110
         </em>
         RFLP typing) belonging to the European-American lineage (based on spoligotyping) has been recognized to be responsible for the largest outbreak of isoniazid-resistant
         <em>
          M. tuberculosis
         </em>
         in Western Europe that was centered in North London [
         <a href="#rid164">
          164,165
         </a>
         ].
        </p>
        <p>
         The reasons why some lineages cause large outbreaks of rapidly progressive disease and others cause reactivation TB are poorly understood. The advent of whole-genome sequence (WGS) analysis of bacterial genomes has revealed several sequence differences associated with
         <em>
          M. tuberculosis
         </em>
         virulence. One such difference is in the so-called region of difference (RD) locus [
         <a href="#rid166">
          166,167
         </a>
         ]. Among members of the
         <em>
          M. tuberculosis
         </em>
         complex, this region, which is found in
         <em>
          M. tuberculosis
         </em>
         reference strain H37Rv, is absent in the vaccine strain
         <em>
          M. bovis
         </em>
         –BCG. Clinical isolates of
         <em>
          M. bovis
         </em>
         often lack RD4, RD5, RD6, RD7, RD8, RD9, RD10, RD12, and RD13 [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         The biological "fitness cost" of drug-resistant
         <em>
          M. tuberculosis
         </em>
         may be influenced by compensatory mutations. Previously, an experimental model showed that
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         resistance in
         <em>
          M. tuberculosis
         </em>
         was associated with competitive fitness cost and that resistant isolates from patients with prolonged treatment exhibited no fitness cost [
         <a href="#rid168">
          168
         </a>
         ]. However, subsequently, many clinical multidrug-resistant strains have been shown to have mutations in the RNA polymerase gene associated with high competitive fitness in vitro and high fitness in vivo [
         <a href="#rid169">
          169
         </a>
         ]. In regions of the world with a high prevalence of multidrug-resistant (MDR-) TB, up to 30 percent of their MDR isolates had such mutations [
         <a href="#rid169">
          169
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          HOST FACTORS
         </span>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Genetic susceptibility to infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Genetic analysis of sibling pairs has been used to evaluate putative genetic markers for enhanced susceptibility to TB in populations in Africa [
         <a href="#rid170">
          170
         </a>
         ]. Possible markers on chromosomes 15q and Xq were identified; the investigators speculate that finding a susceptibility gene on an X chromosome may partially explain the increased incidence of TB in males in some populations.
        </p>
        <p>
         In a mouse model, a locus on chromosome 19 was found to regulate replication of
         <em>
          M. tuberculosis
         </em>
         in the lungs of DBA/2 mice that die rapidly of TB compared with C57BL/6 mice, which are more resistant to infection [
         <a href="#rid171">
          171
         </a>
         ]. In a second study in a mouse model, a single isoform of the intracellular pathogen resistance 1 gene (
         <em>
          Ipr1
         </em>
         ) was found to be responsible for the increased resistance to
         <em>
          M. tuberculosis
         </em>
         infection [
         <a href="#rid172">
          172
         </a>
         ]. Resistance was characterized by smaller lung lesions containing fewer macrophages, slower
         <em>
          M. tuberculosis
         </em>
         growth in macrophages, and death of
         <em>
          M. tuberculosis
         </em>
         –infected macrophages by apoptosis rather than necrosis.
        </p>
        <p>
         The closest human homologue to
         <em>
          lpr1
         </em>
         is
         <em>
          SP110
         </em>
         . A study of families from Guinea-Bissau and the Republic of Guinea identified three polymorphisms in the
         <em>
          SP110
         </em>
         gene that are associated with susceptibility to TB [
         <a href="#rid173">
          173
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Acquired susceptibility to infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Investigators examined the interferon (IFN)-gamma response pathway in three patients with severe, unexplained nontuberculous mycobacterial disease [
         <a href="#rid174">
          174
         </a>
         ]. In all three patients, IFN-gamma was undetectable following stimulation of whole blood but was detectable when stimulated in the absence of the patients' own plasma. An autoantibody against IFN-gamma was isolated from the patients' plasma and was found to be capable of blocking the upregulation of tumor necrosis factor (TNF)-alpha production in response to endotoxin, in blocking induction of IFN-gamma–inducible genes, and in inhibiting upregulation of human leukocyte antigen (HLA) class II expression on peripheral blood mononuclear cells (PBMCs). These acquired defects in the IFN-gamma pathway may explain unusual susceptibilities to intracellular pathogens, including mycobacteria, in patients without underlying, genetically determined immunologic defects.
        </p>
        <p>
         All of the host genes associated with TB susceptibility account for a tiny fraction of all TB cases identified in the world. The most important host factor that determines TB susceptibility to TB is HIV coinfection, followed by other immunosuppressive conditions, including cancer, diabetes, and immunosuppressive medications. Environmental factors, such as crowding, low socioeconomic status, poor access to healthcare, and family history, also contribute substantially to the incidence of TB worldwide, and these are important to understanding TB pathogenesis.
        </p>
        <p class="headingAnchor" id="H1702519057">
         <span class="h2">
          Progression from latent infection to active disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Host factors involved in progression from latent infection to active disease have been described in several reviews [
         <a href="#rid175">
          175,176
         </a>
         ]. One large study in Africa attempted to identify host biosignatures predictive of progression from latent TB infection to disease [
         <a href="#rid177">
          177
         </a>
         ]. The investigators prospectively followed South African adolescents 12 to 18 years of age who were infected with
         <em>
          M. tuberculosis
         </em>
         and compared the blood RNA biosignatures of those who developed TB during the follow-up period with those who did not. The 16 biomarkers identified were found to show a sensitivity and specificity of 54 and 83 percent, respectively, for predicting progression to TB within 12 months preceding TB [
         <a href="#rid177">
          177
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13826771">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inhalation of
         <em>
          Mycobacterium tuberculosis
         </em>
         and deposition in the lungs leads to one of four possible outcomes: immediate clearance of the organism, primary disease (rapid progression to active disease), latent infection (with or without subsequent reactivation disease), or reactivation disease (onset of active disease many years following a period of latent infection). (See
         <a class="local">
          'Natural history of infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The cell envelope is a distinguishing feature of the organisms belonging to the genus
         <em>
          Mycobacterium
         </em>
         . Mycolic acid is the major constituent of the cell envelope; this structure defines the genus. The mycolic acid structure confers the ability to resist destaining by acid alcohol after being stained by certain aniline dyes, leading to the term acid-fast bacillus. (See
         <a class="local">
          'Cell envelope'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microscopy to detect acid-fast bacillus (using Ziehl-Neelsen or Kinyoun stain) is a commonly used procedure for the rapid diagnosis of tuberculosis (TB); a specimen must contain at least 10
         <sup>
          4
         </sup>
         colony forming units (CFU)/mL to yield a positive smear. Microscopy of specimens stained with a fluorochrome dye (such as auramine O provides) is a more sensitive and efficient technique. Microscopic detection of mycobacteria does not distinguish
         <em>
          M. tuberculosis
         </em>
         from nontuberculous mycobacteria. (See
         <a class="local">
          'Staining characteristics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The slow growth rate is a distinguishing feature of
         <em>
          M. tuberculosis
         </em>
         . In artificial media and animal tissues, the generation time is about 20 to 24 hours, which means that cultures may take from two to six weeks for detectable growth, depending on the cultivation systems used for laboratory isolation. (See
         <a class="local">
          'Isolation in the laboratory'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Once the organism is isolated, identification is based upon morphologic and biochemical characteristics, although nucleic acid–based detection methods have obviated many of the conventional tests. The niacin, nitrate reductase, and catalase tests are the three biochemical tests most frequently used to distinguish
         <em>
          M. tuberculosis
         </em>
         from other mycobacterial species. (See
         <a class="local">
          'Identification of the organism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The following virulence factors have been described: mycolic acid glycolipids and trehalose dimycolate (which can elicit granuloma formation in animal tissue), catalase-peroxidase (which resists the host cell oxidative response), sulfatides and trehalose dimycolate (which can trigger toxicity in animal models), lipoarabinomannan (LAM; which can induce cytokines and resist host oxidative stress), and secreted proteins, including CFP10 and ESAT-6. Molecular biology techniques have identified many other gene products that may be involved in the ability of
         <em>
          M. tuberculosis
         </em>
         to enter cells, resist intracellular killing, establish persistence, inhibit host cytosolic surveillance, and come out of latency. (See
         <a class="local">
          'Virulence factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidemiologic studies have revealed a few key
         <em>
          M. tuberculosis
         </em>
         lineages to be overly represented or clustered in certain communities. Such occurrences may relate to these strains' distinct biological "fitness" or transmissibility. (See
         <a class="local">
          'Differences in virulence of clinical isolates'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         TB pathogenesis can be influenced by host-related characteristics that determine outcomes after an infection with
         <em>
          M. tuberculosis
         </em>
         . These may involve host genetic factors that enhance susceptibility to infection or progression to disease after exposure. (See
         <a class="local">
          'Host factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1487673960">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         We are saddened by the death of Lee W Riley, MD, who passed away in October 2022. UpToDate acknowledges Dr. Riley's past work as an author for this topic.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          World Health Organization. Global tuberculosis report 2019. https://www.who.int/tb/publications/global_report/en/ (Accessed on October 28, 2019).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Tuberculosis: Basic TB Facts. http://www.cdc.gov/tb/topic/basics/risk.htm (Accessed on March 10, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med 2014; 190:1044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982; 125:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           National action plan to combat multidrug-resistant tuberculosis. MMWR Recomm Rep 1992; 41:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horsburgh CR Jr, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 2011; 364:1441.
          </a>
         </li>
         <li class="breakAll">
          Rich A. The Pathogenesis of Tuberculosis, Charles C Thomas, Springfield 1951.
         </li>
         <li class="breakAll">
          Dubos R, Dubos J. The White Plague: Tuberculosis, Man, and Society, Little, Brown, Boston 1952.
         </li>
         <li class="breakAll">
          Lurie MB. Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defense Mechanisms, Harvard University Press, Cambridge 1964.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collins FM, Campbell SG. Immunity to intracellular bacteria. Vet Immunol Immunopathol 1982; 3:5.
          </a>
         </li>
         <li class="breakAll">
          Dannenberg AM Jr, Tomashefski JF Jr. Pathogenesis of pulmonary tuberculosis. In: Pulmonary Diseases and Disorders, 2nd ed, Fishman AP (Ed), McGraw-Hill, New York 1988. Vol 3.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung AN. Pulmonary tuberculosis: the essentials. Radiology 1999; 210:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes HL, Barnes LR. The Duration of Life in Pulmonary Tuberculosis with Cavity. Trans Am Climatol Clin Assoc 1928; 44:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trauer JM, Moyo N, Tay EL, et al. Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%? Chest 2016; 149:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bates MN, Khalakdina A, Pai M, et al. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith GS, Van Den Eeden SK, Baxter R, et al. Cigarette smoking and pulmonary tuberculosis in northern California. J Epidemiol Community Health 2015; 69:568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heimbeck J. The infection of tuberculosis. Acta Med Scand 1930; 74:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andrews JR, Noubary F, Walensky RP, et al. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2012; 54:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahey T, Mackenzie T, Arbeit RD, et al. Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis. Clin Infect Dis 2013; 56:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verver S, Warren RM, Beyers N, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171:1430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ 2018; 362:k2738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dale KD, Trauer JM, Dodd PJ, et al. Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants. Clin Infect Dis 2020; 70:2111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horsburgh CR. "Plus Ça Change…". Clin Infect Dis 2020; 70:2119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tornieporth NG, Ptachewich Y, Poltoratskaia N, et al. Tuberculosis among foreign-born persons in New York City, 1992-1994: implications for tuberculosis control. Int J Tuberc Lung Dis 1997; 1:528.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Tuberculosis (TB). https://www.cdc.gov/tb/default.htm (Accessed on November 18, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kik SV, Mensen M, Beltman M, et al. Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country. Int J Tuberc Lung Dis 2011; 15:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korthals Altes H, Kloet S, Cobelens F, Bootsma M. Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling. PLoS One 2018; 13:e0192282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menzies NA, Wolf E, Connors D, et al. Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. Lancet Infect Dis 2018; 18:e228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Soolingen D, Hoogenboezem T, de Haas PE, et al. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 1997; 47:1236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ingen J, Rahim Z, Mulder A, et al. Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies. Emerg Infect Dis 2012; 18:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McNeil MR, Brennan PJ. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Res Microbiol 1991; 142:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffmann C, Leis A, Niederweis M, et al. Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci U S A 2008; 105:3963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhanot N, Zaman MM. An immigrant with a painful swelling in his back. Clin Infect Dis 2007; 44:1615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen BW, Mitchison DA. Counts of viable tubercle bacilli in sputum related to smear and culture gradings. Med Lab Sci 1992; 49:94.
          </a>
         </li>
         <li class="breakAll">
          Kent PT, Kubica GP. Public health mycobacteriology: A guide for the level III laboratory. Centers for Disease Control, US PHS. 1985.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.
          </a>
         </li>
         <li class="breakAll">
          Hanna BA. Diagnosis of tuberculosis by microbiologic techniques. In: Tuberculosis, Rom WN, Garay S (Eds), Little, Brown, Boston 1995.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts GD, Goodman NL, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983; 18:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morgan MA, Horstmeier CD, DeYoung DR, Roberts GD. Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol 1983; 18:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Amato RF, Isenberg HD, Hochstein L, et al. Evaluation of the Roche Septi-Chek AFB system for recovery of mycobacteria. J Clin Microbiol 1991; 29:2906.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pfyffer GE, Welscher HM, Kissling P, et al. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol 1997; 35:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aggarwal P, Singal A, Bhattacharya SN, Mishra K. Comparison of the radiometric BACTEC 460 TB culture system and Löwenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern. Int J Dermatol 2008; 47:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol 2006; 44:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kasărov LB, Moat AG. Metabolism of nicotinamide adenine dinucleotide in human and bovine strainsof Mycobacterium tuberculosis. J Bacteriol 1972; 110:600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vestal AL, Kubica GP. Differential identification of mycobacteria. 3. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide, and triphenyltetrazolium chloride. Scand J Respir Dis 1967; 48:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 1996; 2:662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537.
          </a>
         </li>
         <li class="breakAll">
          Sanger Institute. Mycobacterium. http://www.sanger.ac.uk/resources/downloads/bacteria/mycobacterium.html (Accessed on February 24, 2015).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ross BC, Raios K, Jackson K, Dwyer B. Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool. J Clin Microbiol 1992; 30:942.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groenen PM, Bunschoten AE, van Soolingen D, van Embden JD. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method. Mol Microbiol 1993; 10:1057.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramakrishnan L, Federspiel NA, Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 2000; 288:1436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tufariello JM, Chapman JR, Kerantzas CA, et al. Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence. Proc Natl Acad Sci U S A 2016; 113:E348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitra A, Speer A, Lin K, et al. PPE Surface Proteins Are Required for Heme Utilization by Mycobacterium tuberculosis. mBio 2017; 8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daleke MH, Ummels R, Bawono P, et al. General secretion signal for the mycobacterial type VII secretion pathway. Proc Natl Acad Sci U S A 2012; 109:11342.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ates LS. New insights into the mycobacterial PE and PPE proteins provide a framework for future research. Mol Microbiol 2020; 113:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan J, Fan XD, Hunter SW, et al. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 1991; 59:1755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rastogi N, David HL. Mechanisms of pathogenicity in mycobacteria. Biochimie 1988; 70:1101.
          </a>
         </li>
         <li class="breakAll">
          Stewart-Tull DE. Immunologically important constituents of Mycobacteria: Adjuvants. In: Biology of the Mycobacteria, Ratledge C, Stanford J (Eds), Academic Press, London 1983. Vol 2.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barksdale L, Kim KS. Mycobacterium. Bacteriol Rev 1977; 41:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goren MB, Brokl O, Schaefer WB. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infect Immun 1974; 9:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           BLOCH H, SEGAL W. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J Bacteriol 1956; 72:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003; 16:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orgeur M, Brosch R. Evolution of virulence in the Mycobacterium tuberculosis complex. Curr Opin Microbiol 2018; 41:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forrellad MA, Klepp LI, Gioffré A, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence 2013; 4:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manca C, Tsenova L, Freeman S, et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 2005; 25:694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedman CR, Quinn GC, Kreiswirth BN, et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis 1997; 176:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valway SE, Sanchez MP, Shinnick TF, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998; 338:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cantrell SA, Pascopella L, Flood J, et al. Community-wide transmission of a strain of Mycobacterium tuberculosis that causes reduced lung pathology in mice. J Med Microbiol 2008; 57:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manca C, Tsenova L, Barry CE 3rd, et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999; 162:6740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reed MB, Domenech P, Manca C, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004; 431:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ehrt S, Shiloh MU, Ruan J, et al. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med 1997; 186:1885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isberg RR, Falkow S. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 1985; 317:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arruda S, Bomfim G, Knights R, et al. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science 1993; 261:1454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castranova V, Rabovsky J, Tucker JH, Miles PR. The alveolar type II epithelial cell: a multifunctional pneumocyte. Toxicol Appl Pharmacol 1988; 93:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shimono N, Morici L, Casali N, et al. Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci U S A 2003; 100:15918.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uchida Y, Casali N, White A, et al. Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator. Cell Microbiol 2007; 9:1275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casali N, Riley LW. A phylogenomic analysis of the Actinomycetales mce operons. BMC Genomics 2007; 8:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A 2008; 105:4376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunphy KY, Senaratne RH, Masuzawa M, et al. Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5. J Infect Dis 2010; 201:1232.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cantrell SA, Leavell MD, Marjanovic O, et al. Free mycolic acid accumulation in the cell wall of the mce1 operon mutant strain of Mycobacterium tuberculosis. J Microbiol 2013; 51:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forrellad MA, McNeil M, Santangelo Mde L, et al. Role of the Mce1 transporter in the lipid homeostasis of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2014; 94:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Queiroz A, Medina-Cleghorn D, Marjanovic O, et al. Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains. Pathog Dis 2015; 73:ftv066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nazarova EV, Montague CR, Huang L, et al. The genetic requirements of fatty acid import by Mycobacterium tuberculosis within macrophages. Elife 2019; 8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Queiroz A, Riley LW. Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response. Rev Soc Bras Med Trop 2017; 50:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collins DM. In search of tuberculosis virulence genes. Trends Microbiol 1996; 4:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKinney JD, Höner zu Bentrup K, Muñoz-Elías EJ, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000; 406:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubnau E, Chan J, Mohan VP, Smith I. responses of mycobacterium tuberculosis to growth in the mouse lung. Infect Immun 2005; 73:3754.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuan Y, Zhu Y, Crane DD, Barry CE 3rd. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol 1998; 29:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao V, Fujiwara N, Porcelli SA, Glickman MS. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 2005; 201:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glickman MS, Cox JS, Jacobs WR Jr. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 2000; 5:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285:732.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camacho LR, Constant P, Raynaud C, et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem 2001; 276:19845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox JS, Chen B, McNeil M, Jacobs WR Jr. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 1999; 402:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Champion PA, Cox JS. Protein secretion systems in Mycobacteria. Cell Microbiol 2007; 9:1376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camacho LR, Ensergueix D, Perez E, et al. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 1999; 34:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guinn KM, Hickey MJ, Mathur SK, et al. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 2004; 51:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Wel N, Hava D, Houben D, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007; 129:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Augenstreich J, Arbues A, Simeone R, et al. ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis. Cell Microbiol 2017; 19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brodin P, Majlessi L, Marsollier L, et al. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun 2006; 74:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A 2003; 100:13001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voulhoux R, Ball G, Ize B, et al. Involvement of the twin-arginine translocation system in protein secretion via the type II pathway. EMBO J 2001; 20:6735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pradel N, Ye C, Livrelli V, et al. Contribution of the twin arginine translocation system to the virulence of enterohemorrhagic Escherichia coli O157:H7. Infect Immun 2003; 71:4908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossier O, Cianciotto NP. The Legionella pneumophila tatB gene facilitates secretion of phospholipase C, growth under iron-limiting conditions, and intracellular infection. Infect Immun 2005; 73:2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolf AJ, Linas B, Trevejo-Nuñez GJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007; 179:2509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012; 7:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A 1999; 96:14459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001; 291:1544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002; 4:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Means TK, Wang S, Lien E, et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163:3920.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Means TK, Jones BW, Schromm AB, et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001; 166:4074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rocha-Ramírez LM, Estrada-García I, López-Marín LM, et al. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb) 2008; 88:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandey AK, Yang Y, Jiang Z, et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 2009; 5:e1000500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gandotra S, Jang S, Murray PJ, et al. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect Immun 2007; 75:5127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Divangahi M, Mostowy S, Coulombe F, et al. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 2008; 181:7157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Austin CM, Ma X, Graviss EA. Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. J Infect Dis 2008; 197:1713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan H, Dai Y, Tang S, Wang J. Polymorphisms of NOD2 and the risk of tuberculosis: a validation study in the Chinese population. Int J Immunogenet 2012; 39:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh V, Gaur R, Mittal M, et al. Absence of nucleotide-binding oligomerization domain-containing protein 2 variants in patients with leprosy and tuberculosis. Int J Immunogenet 2012; 39:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donovan ML, Schultz TE, Duke TJ, Blumenthal A. Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences. Front Immunol 2017; 8:1633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chin KL, Anis FZ, Sarmiento ME, et al. Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis. J Immunol Res 2017; 2017:5212910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corrigan RM, Gründling A. Cyclic di-AMP: another second messenger enters the fray. Nat Rev Microbiol 2013; 11:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woodward JJ, Iavarone AT, Portnoy DA. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 2010; 328:1703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burdette DL, Monroe KM, Sotelo-Troha K, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011; 478:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013; 13:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bai Y, Yang J, Zhou X, et al. Mycobacterium tuberculosis Rv3586 (DacA) is a diadenylate cyclase that converts ATP or ADP into c-di-AMP. PLoS One 2012; 7:e35206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dey B, Dey RJ, Cheung LS, et al. A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. Nat Med 2015; 21:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Philips JA. Mycobacterial manipulation of vacuolar sorting. Cell Microbiol 2008; 10:2408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vergne I, Chua J, Lee HH, et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2005; 102:4033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bach H, Papavinasasundaram KG, Wong D, et al. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 2008; 3:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun J, Wang X, Lau A, et al. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS One 2010; 5:e8769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saitoh T, Akira S. Regulation of inflammasomes by autophagy. J Allergy Clin Immunol 2016; 138:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deretic V. Autophagy in tuberculosis. Cold Spring Harb Perspect Med 2014; 4:a018481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watson RO, Manzanillo PS, Cox JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012; 150:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dutta RK, Kathania M, Raje M, Majumdar S. IL-6 inhibits IFN-γ induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages. Int J Biochem Cell Biol 2012; 44:942.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seto S, Tsujimura K, Horii T, Koide Y. Autophagy adaptor protein p62/SQSTM1 and autophagy-related gene Atg5 mediate autophagosome formation in response to Mycobacterium tuberculosis infection in dendritic cells. PLoS One 2013; 8:e86017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakowski ET, Koster S, Portal Celhay C, et al. Ubiquilin 1 Promotes IFN-γ-Induced Xenophagy of Mycobacterium tuberculosis. PLoS Pathog 2015; 11:e1005076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           PIERCE CH, DUBOS RJ, SCHAEFER WB. Multiplication and survival of tubercle bacilli in the organs of mice. J Exp Med 1953; 97:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           North RJ, Izzo AA. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J Exp Med 1993; 177:1723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gideon HP, Phuah J, Myers AJ, et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog 2015; 11:e1004603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scanga CA, Flynn JL. Modeling tuberculosis in nonhuman primates. Cold Spring Harb Perspect Med 2014; 4:a018564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 1996; 64:2062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeMaio J, Zhang Y, Ko C, et al. A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 1996; 93:2790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuan Y, Crane DD, Barry CE 3rd. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol 1996; 178:4484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yuan Y, Crane DD, Simpson RM, et al. The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A 1998; 95:9578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Höner Zu Bentrup K, Miczak A, Swenson DL, Russell DG. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis. J Bacteriol 1999; 181:7161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graham JE, Clark-Curtiss JE. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U S A 1999; 96:11554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muñoz-Elías EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 2005; 11:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sherman DR, Voskuil M, Schnappinger D, et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A 2001; 98:7534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park HD, Guinn KM, Harrell MI, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 2003; 48:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin MY, Reddy TB, Arend SM, et al. Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria. Infect Immun 2009; 77:5071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Click ES, Moonan PK, Winston CA, et al. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis 2012; 54:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cowley D, Govender D, February B, et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 2008; 47:1252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang C, Luo T, Sun G, et al. Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China. Clin Infect Dis 2012; 55:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huyen MN, Buu TN, Tiemersma E, et al. Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections. J Infect Dis 2013; 207:1516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agerton TB, Valway SE, Blinkhorn RJ, et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis 1999; 29:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marais BJ, Victor TC, Hesseling AC, et al. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol 2006; 44:3539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buu TN, Huyen MN, van Soolingen D, et al. The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam. Clin Infect Dis 2010; 51:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parwati I, Alisjahbana B, Apriani L, et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis 2010; 201:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong Y, Cave MD, Zhang L, et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J Clin Microbiol 2007; 45:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caws M, Thwaites G, Stepniewska K, et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006; 44:3934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsenova L, Ellison E, Harbacheuski R, et al. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 2005; 192:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grode L, Seiler P, Baumann S, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Invest 2005; 115:2472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Firmani MA, Riley LW. Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro. Infect Immun 2002; 70:3965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newton SM, Smith RJ, Wilkinson KA, et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci U S A 2006; 103:15594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shorten RJ, McGregor AC, Platt S, et al. When is an outbreak not an outbreak? Fit, divergent strains of Mycobacterium tuberculosis display independent evolution of drug resistance in a large London outbreak. J Antimicrob Chemother 2013; 68:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Satta G, Witney AA, Shorten RJ, et al. Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance. BMC Med 2016; 14:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahairas GG, Sabo PJ, Hickey MJ, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996; 178:1274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999; 284:1520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagneux S, Long CD, Small PM, et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006; 312:1944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comas I, Borrell S, Roetzer A, et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 2011; 44:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bellamy R, Beyers N, McAdam KP, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A 2000; 97:8005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitsos LM, Cardon LR, Ryan L, et al. Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci U S A 2003; 100:6610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pan H, Yan BS, Rojas M, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosh K, Campbell SJ, Fielding K, et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci U S A 2006; 103:10364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 2005; 115:2480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallis RS, Maeurer M, Mwaba P, et al. Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect Dis 2016; 16:e34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goletti D, Petruccioli E, Joosten SA, Ottenhoff TH. Tuberculosis Biomarkers: From Diagnosis to Protection. Infect Dis Rep 2016; 8:6568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zak DE, Penn-Nicholson A, Scriba TJ, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 2016; 387:2312.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8023 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://www.who.int/tb/publications/global_report/en/" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : World Health Organization. Global tuberculosis report 2019. https://www.who.int/tb/publications/global_report/en/ (Accessed on October 28, 2019).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://www.cdc.gov/tb/topic/basics/risk.htm" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Centers for Disease Control and Prevention. Tuberculosis: Basic TB Facts. http://www.cdc.gov/tb/topic/basics/risk.htm (Accessed on March 10, 2015).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25265362" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7073104" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Epidemiology of tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1640920" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : National action plan to combat multidrug-resistant tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21488766" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Clinical practice. Latent tuberculosis infection in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21488766" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Clinical practice. Latent tuberculosis infection in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21488766" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Clinical practice. Latent tuberculosis infection in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21488766" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Clinical practice. Latent tuberculosis infection in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6213089" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Immunity to intracellular bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6213089" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Immunity to intracellular bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10207408" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Pulmonary tuberculosis: the essentials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21408948" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The Duration of Life in Pulmonary Tuberculosis with Cavity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26867835" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17325294" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25605864" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Cigarette smoking and pulmonary tuberculosis in northern California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The infection of tuberculosis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22267721" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22972862" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15831840" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30139910" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Revisiting the timetable of tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31246254" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31265722" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : "PlusÇa Change…".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9487451" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Tuberculosis among foreign-born persons in New York City, 1992-1994: implications for tuberculosis control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9487451" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Tuberculosis among foreign-born persons in New York City, 1992-1994: implications for tuberculosis control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21276294" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29444122" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29653698" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9336935" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22469053" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1871433" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18316738" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17516406" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : An immigrant with a painful swelling in his back.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1487984" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Counts of viable tubercle bacilli in sputum related to smear and culture gradings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1487984" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Counts of viable tubercle bacilli in sputum related to smear and culture gradings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10764337" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10764337" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6195181" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6194175" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1757573" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Evaluation of the Roche Septi-Chek AFB system for recovery of mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9003597" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18613873" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Comparison of the radiometric BACTEC 460 TB culture system and Löwenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16390942" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4336690" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Metabolism of nicotinamide adenine dinucleotide in human and bovine strainsof Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4168884" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Differential identification of mycobacteria. 3. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide, and triphenyltetrazolium chloride.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8640557" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9634230" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9634230" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1572981" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7934856" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10827956" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26729876" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28119467" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : PPE Surface Proteins Are Required for Heme Utilization by Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22733768" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : General secretion signal for the mycobacterial type VII secretion pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31661176" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : New insights into the mycobacterial PE and PPE proteins provide a framework for future research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1850379" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3147701" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Mechanisms of pathogenicity in mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3147701" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Mechanisms of pathogenicity in mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/67839" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Mycobacterium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4202886" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13366889" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12857778" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29216510" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Evolution of virulence in the Mycobacterium tuberculosis complex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23076359" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Virulence factors of the Mycobacterium tuberculosis complex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16318583" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9237715" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9486991" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18065663" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Community-wide transmission of a strain of Mycobacterium tuberculosis that causes reduced lung pathology in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10352293" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15343336" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9382887" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : A novel antioxidant gene from Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2995819" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8367727" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3285521" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : The alveolar type II epithelial cell: a multifunctional pneumocyte.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14663145" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17223927" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17324287" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : A phylogenomic analysis of the Actinomycetales mce operons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18334639" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Mycobacterial persistence requires the utilization of host cholesterol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20214478" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24037657" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Free mycolic acid accumulation in the cell wall of the mce1 operon mutant strain of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24440549" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Role of the Mce1 transporter in the lipid homeostasis of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26319139" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30735132" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : The genetic requirements of fatty acid import by Mycobacterium tuberculosis within macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28327797" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8950811" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : In search of tuberculosis virulence genes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10963599" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15908407" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : responses of mycobacterium tuberculosis to growth in the mouse lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9781881" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15710652" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10882107" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10426995" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11279114" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10573420" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17466013" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Protein secretion systems in Mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10564470" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14756778" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17604718" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28095608" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16368961" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14557536" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11726509" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Involvement of the twin-arginine translocation system in protein secretion via the type II pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12933832" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Contribution of the twin arginine translocation system to the virulence of enterohemorrhagic Escherichia coli O157:H7.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15784543" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : The Legionella pneumophila tatB gene facilitates secretion of phospholipase C, growth under iron-limiting conditions, and intracellular infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17675513" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22054143" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Tuberculosis pathogenesis and immunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10588727" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11222859" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Induction of direct antimicrobial activity through mammalian toll-like receptors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12106786" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : The role of Toll-like receptors in immunity against mycobacterial infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10490993" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11238656" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18222732" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19578435" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17709422" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18981137" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18419343" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22212192" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Polymorphisms of NOD2 and the risk of tuberculosis: a validation study in the Chinese population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22289211" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Absence of nucleotide-binding oligomerization domain-containing protein 2 variants in patients with leprosy and tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29230217" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28713838" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23812326" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Cyclic di-AMP: another second messenger enters the fray.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20508090" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21947006" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : STING is a direct innate immune sensor of cyclic di-GMP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24064518" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Autophagy in infection, inflammation and immunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22529992" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Mycobacterium tuberculosis Rv3586 (DacA) is a diadenylate cyclase that converts ATP or ADP into c-di-AMP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25730264" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18783482" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Mycobacterial manipulation of vacuolar sorting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15753315" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18474358" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20098737" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27373323" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Regulation of inflammasomes by autophagy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25167980" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Autophagy in tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22901810" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22426116" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : IL-6 inhibits IFN-γinduced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24376899" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Autophagy adaptor protein p62/SQSTM1 and autophagy-related gene Atg5 mediate autophagosome formation in response to Mycobacterium tuberculosis infection in dendritic cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26225865" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Ubiquilin 1 Promotes IFN-γ-Induced Xenophagy of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13022873" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Multiplication and survival of tubercle bacilli in the organs of mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8496688" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25611466" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25213189" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Modeling tuberculosis in nonhuman primates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8675308" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8610119" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8755875" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9689123" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10572116" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10500215" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15895072" id="rid145" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          146 : Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11416222" id="rid146" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          147 : Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12694625" id="rid147" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          148 : Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19737909" id="rid148" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          149 : Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22198989" id="rid149" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          150 : Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18834315" id="rid150" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          151 : Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22865872" id="rid151" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          152 : Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23408848" id="rid152" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          153 : Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10433569" id="rid153" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          154 : Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16928967" id="rid154" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          155 : Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20836697" id="rid155" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          156 : The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20064071" id="rid156" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          157 : Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17166963" id="rid157" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          158 : Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16971650" id="rid158" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          159 : Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15942899" id="rid159" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          160 : Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16110326" id="rid160" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          161 : Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12065545" id="rid161" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          162 : Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17028173" id="rid162" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          163 : A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23129727" id="rid163" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          164 : When is an outbreak not an outbreak? Fit, divergent strains of Mycobacterium tuberculosis display independent evolution of drug resistance in a large London outbreak.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27530812" id="rid164" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          165 : Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8631702" id="rid165" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          166 : Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10348738" id="rid166" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          167 : Comparative genomics of BCG vaccines by whole-genome DNA microarray.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16809538" id="rid167" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          168 : The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22179134" id="rid168" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          169 : Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10859364" id="rid169" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          170 : Genetic susceptibility to tuberculosis in Africans: a genome-wide scan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12740444" id="rid170" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          171 : Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15815631" id="rid171" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          172 : Ipr1 gene mediates innate immunity to tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16803959" id="rid172" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          173 : Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16127458" id="rid173" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          174 : Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27036358" id="rid174" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          175 : Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27403267" id="rid175" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          176 : Tuberculosis Biomarkers: From Diagnosis to Protection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27017310" id="rid176" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          177 : A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
